2019
Omics and coagulation disorders in pregnancy
Ornaghi S, Paidas M. Omics and coagulation disorders in pregnancy. 2019, 149-155. DOI: 10.1201/9781315201955-24.Peer-Reviewed Original ResearchFetal growth restrictionOmics technologiesPlacenta-mediated complicationsMaternal thromboembolismSpecific biological sampleCoagulation disordersMolecular basisBiochemical pathwaysRegistry-based studyMessenger RNADifferent clinical conditionsVascular biologyPlacental abruptionFetal lossGrowth restrictionRisk factorsClinical conditionsLarge cohortNonbiased mannerBiomarker developmentThromboembolismPreeclampsiaComplicationsPregnancyRelevant diseases
2012
Inherited and Acquired Thrombophilias
Paidas M. Inherited and Acquired Thrombophilias. 2012, 108-120. DOI: 10.1002/9781119963783.ch15.Peer-Reviewed Original ResearchAntiphospholipid antibody syndromePlacenta-mediated complicationsAntibody syndromeThrombophilic conditionsProthrombin G20210A gene mutationFactor V Leiden mutationBenefits of anticoagulationCornerstone of treatmentProspective cohort studyRecurrent pregnancy lossAdequate clinical trialsV Leiden mutationAcquired ThrombophiliaAntiplatelet therapyCohort studyPregnancy lossThrombophilic mutationsClinical trialsLeiden mutationNatural anticoagulantsRoutine useThrombophiliaGene mutationsAnticoagulationComplications